We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Research Progress in Ulcerative Colitis: The Role of Traditional Chinese Medicine on Gut Microbiota and Signaling Pathways.
- Authors
Zhang, Yuyi; Zhu, Mingfang; Dai, Yueying; Gao, Longying; Cheng, Limin
- Abstract
Ulcerative colitis (UC), one among other refractory diseases worldwide, has shown an increasing trend of progression to colorectal cancer in recent years. In the treatment of UC, traditional Chinese medicine has demonstrated good efficacy, with a high cure rate, fewer adverse effects, great improvement in the quality of patient survival, and reduction in the tendency of cancerous transformation. It shows promise as a complementary and alternative therapy. This review aims to evaluate and discuss the current research on UC, signaling pathways, and gut microbiota. We also summarized the mechanisms of action of various Chinese medicines (active ingredients or extracts) and herbal formulas, through signaling pathways and gut microbiota, with the expectation that they can provide references and evidence for treating UC and preventing inflammation-associated colorectal cancer by traditional Chinese medicine. We illustrate that multiple signaling pathways, such as TLR4, STAT3, PI3K/Akt, NF- κ B, and Keap1/Nrf2, can be inhibited by Chinese herbal treatments through the combined regulation of signaling pathways and gut microbiota, which can act individually or synergistically to inhibit intestinal inflammatory cell infiltration, attenuate gut oxidative responses, and repair the intestinal barrier.
- Subjects
INFLAMMATION prevention; CHINESE medicine; NF-kappa B; MITOGEN-activated protein kinases; SHIGELLA; HERBAL medicine; GUT microbiome; ULCERATIVE colitis; CELLULAR signal transduction; COLORECTAL cancer; OXIDATIVE stress; CYTOSKELETAL proteins; ENTEROBACTERIACEAE; DRUG efficacy; ESCHERICHIA; LACTOBACILLUS; ACTINOBACTERIA; PEROXISOME proliferator-activated receptors; PHOSPHOTRANSFERASES; STAT proteins; SIGNAL peptides; DISEASE progression; NUCLEAR factor E2 related factor
- Publication
American Journal of Chinese Medicine, 2024, Vol 52, Issue 8, p2277
- ISSN
0192-415X
- Publication type
Academic Journal
- DOI
10.1142/S0192415X24500885